Applied Biosystems to Webcast Investor Presentations on June 23.

FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast management presentations to be given on Friday, June 23, 2006 by executives of Applied Biosystems/MDS Sciex Instruments, a joint venture between Applied Biosystems and MDS Inc. Stephen P. DeFalco, President and Chief Executive Officer, MDS Inc.; Laura Lauman, Division President, Protein & Small Molecule Division, Applied Biosystems; and Andy Boorn, President, MDS Sciex, will discuss the joint venture's operations, products, and end markets and answer questions from members of the financial community attending the meeting at the MDS Sciex facility in Toronto, Ontario, Canada. The live webcast is scheduled to begin at 10:30 am ET.

The joint venture, a global leader in providing mass spectrometry systems for life sciences applications, celebrates its 20th anniversary this year.

Interested parties may access the live webcast and replay by visiting the Investors section of the Applied Biosystems web site at http://ir.appliedbiosystems.com or the Investors & Media section of the Applera web site at www.applera.com. It is suggested that interested parties access the webcast 15 minutes before the start of the live webcast. The webcast replay will be archived on the Presentations page of the Investors section of each website.

About Applera Corporation and Applied Biosystems

Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of nearly $1.8 billion during fiscal 2005. The Celera Genomics Group is focused on discovery, development, and commercialization of diagnostic products as well as leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com.

(C)Copyright 2006. Applera Corporation. All rights reserved. Applied Biosystems and Celera are registered trademarks and Applera and Celera Genomics are trademarks of Applera Corporation or its subsidiaries in the U.S. and/or certain other countries.